Pfizer Viagra revenue 2003-2019| ��ƽ��

Worldwide revenue of Pfizer's Viagra from 2003 to 2019 (in million U.S. dollars)

Characteristic	Revenue in million U.S. dollars
2019	497
2018*	636
2017	1,204
2016	1,564
2015	1,708
2014	1,685
2013	1,881
2012	2,051
2011	1,981
2010	1,928
2009	1,892
2008	1,934
2007	1,764
2006	1,657
2005	1,645
2004	1,678
2003	1,879

Download

Source

Show detailed source information?

Already a member?

Source

Release date

February 2020

More information

Region

Worldwide

Survey time period

2003 to 2019

Supplementary notes

This statistic was assembled from several of Pfizer's annual and financial reports.
* Viagra lost exclusivity in the U.S. in December 2017. In 2018, revenues for Viagra in the U.S. and Canada, which were reported in IH through 2017, were reported in EH (which reported all other Viagra revenues excluding the U.S. and Canada through 2017). Therefore, in 2018, total Viagra worldwide revenues were reported in EH. Total Viagra revenues in 2017 and 2016 represented the aggregate of worldwide revenues from Viagra IH and Viagra EH.

Citation formats

Pfizer’s worldwide known erectile dysfunction product Viagra generated around 500 million U.S. dollars in revenue in 2019. Sales of this drug have decreased steadily over the past seven years, especially because patent protection expired outside the U.S. in 2012. In the United States, several drug manufacturers are currently allowed to market generic versions of Viagra (sildenafil), even if the patent is set to expire in 2020. This was the reason behind a further significant decline in sales in 2017-2018.

Drug manufacturer Pfizer

Drug manufacturer Pfizer is currently the world’s leading pharmaceutical company based on pure pharmaceutical sales of prescribed and over-the-counter drugs. The company is headquartered in Midtown Manhattan, New York City. Until 2013, the company also had a notable animal health product line. Today, the company is totally focused on human medicine, divided into two major segments - Innovative Health and Essential Health. Pfizer generates nearly half of its revenues inside the United States.

The rise of Viagra

Viagra was developed by scientists that were originally working on a drug for the treatment of hypertension and angina pectoris. During one of the trial phases the ‘adverse effect’ became obvious – while the targeted angina pectoris showed no improvement. Thus, it was approved for the market as an orally administered drug for erectile dysfunction in 1998. Pfizer’s Viagra has surely been one of the best-known and most discussed pharmaceutical products over the last few decades, entering even popular culture and becoming a synonym for potency. The drug, however, is also approved for treating pulmonary arterial hypertension.